Divya Patel

PGY-1 IM @ahnimres | B.J Medical College, India | Tennis | Ultra-Cyclist, Road Biking is my thing

[Divya Patel @impateldivya]

Thrilled to present our work at ACC 2026 as a Moderated Oral Presentation, with simultaneous publication in JACC EP.

Excited to share our retrospective cohort study comparing GLP-1 receptor agonists vs bariatric surgery in patients with obesity undergoing AF ablation.

🧠 Key Findings:
• Lower AF readmissions
• Lower HF readmissions
• Lower all-cause readmissions
• Lower all-cause mortality
• Lower antiarrhythmic drug use
• No significant difference in stroke, redo ablation, or cardioversion

These findings support the potential role of GLP-1RAs as an adjunctive strategy after AF ablation.

https://t.co/swVBIvBVUo

@harsh_cardio @nair_ambica Rutvij Patel @AakashRSheth @SidAgarwalMBBS @TheRhythmDoc Freddy Del-Carpio Munoz @abhishek_mbbs @DrDeese99

@JACCJournals @ACCinTouch
@MayoClinicCV @AHNIMres @TKapetanos @KhandelwalMD

#ACC2026 #JACCEP #Cardiology #AtrialFibrillation

[Divya Patel @impateldivya]

@TKapetanos @KhandelwalMD @DanDaviesMD @AHN_CVI @AHNIMres Thank you!

[Divya Patel @impateldivya]

Grateful for the opportunity to present and learn at the AHN Cardiovascular Symposium in Bedford, PA. Thank you @KhandelwalMD, Dr. Khalil, @DanDaviesMD , and @TKapetanos for the guidance and support.

@AHN_CVI @AHNIMres

[Siddharth Agarwal (he/him) @SidAgarwalMBBS]

New in @JCardioEP
In dialysis-dependent ESRD patients, leadless pacemakers were associated with fewer device re-interventions vs transvenous pacemakers over 5 years, with similar mortality and complication rates.
@abhishek_mbbs @DrDeese99

[Siddharth Agarwal (he/him) @SidAgarwalMBBS]

New in @JCardioEP
In a large real-world cohort of patients with HCM and AF, catheter ablation was associated with fewer HF exacerbations and reduced AAD-related adverse events compared with medical therapy along with lower all-cause mortality.
@abhishek_mbbs @DrDeese99

[Rutvij Patel @RutvijPatelRV]

🎉 Excited to share our paper is now featured on @Healio & @MedPageToday!

In patients with obesity undergoing AF ablation, GLP-1 receptor agonists were associated with lower AF readmission, HF hospitalization, and mortality compared to bariatric surgery.

Published in JACC: Clinical Electrophysiology

👥 @harsh_cardio @DrDeese99 @abhishek_mbbs @TheRhythmDoc @SidAgarwalMBBS @nair_ambica

🔗 Healio: https://t.co/oH4k6kBdkV

🔗 MedPage Today: https://t.co/OnQy7PFVnQ

#AFib #GLP1 #Cardiology #Electrophysiology

[Divya Patel @impateldivya]

@MayoClinicCVS @MayoEPFellows @MayoCVFellows
@MayoClinic @AHNIMres @AHN_CVI

@harsh_cardio @nair_ambica @RutvijPatelRV @AakashRSheth @SidAgarwalMBBS
Freddy Del-Carpio Munoz

[Divya Patel @impateldivya]

Featured on @GoHealio after our Moderated Oral Presentation at ACC26 and simultaneous publication in JACC EP: in patients with obesity undergoing AF ablation, GLP-1 receptor agonists were associated with significantly lower AF readmission, HF hospitalization, all-cause readmission, and mortality compared with bariatric surgery.

https://t.co/bCHpeHLh7C
@ACCinTouch @JACCJournals
@abhishek_mbbs @DrDeese99
@TheRhythmDoc

[Divya Patel @impateldivya]

@harsh_cardio @nair_ambica @RutvijPatelRV @AakashRSheth @SidAgarwalMBBS Freddy Del-Carpio Munoz

[Divya Patel @impateldivya]

Grateful to see our work highlighted by MedPage Today and reaching a wider audience. Exciting to see growing interest in the relationship between GLP-1 therapies and atrial fibrillation outcomes.

"GLP-1 Drugs Show Growing Promise for Afib Control" https://t.co/8Y6uwQG02a

@medpagetoday @nicolejlou @JACCJournals @ACCinTouch

@harsh_cardio @DrDeese99 @abhishek_mbbs @TheRhythmDoc

#ACC2026 #JACCEP #CardioTwitter

[Divya Patel @impateldivya]

Among obese patients undergoing catheter ablation for #AFib, post-ablation GLP-1RA therapy was associated with better long-term outcomes than bariatric surgery, including lower AF readmission, HF readmission, all-cause readmission, and mortality in a propensity-matched cohort. These findings highlight the potential role of GLP-1RAs as an adjunct in rhythm management strategies and support the need for prospective randomized trials.
https://t.co/uCqH5CA46d
@JACCJournals @ACCinTouch

#ACC2026 #JACCEP #Cardiology #AtrialFibrillation

[Divya Patel @impateldivya]

What a fun Moderated Oral Presentation and Q&A at ACC 2026. Grateful for the opportunity to present our work and for the engaging discussion that followed.

Very thankful to @harsh_cardio @nair_ambica Rutvij Patel @AakashRSheth @SidAgarwalMBBS @TheRhythmDoc Freddy Del-Carpio Munoz @abhishek_mbbs @DrDeese9 for their mentorship, support, and collaboration. Truly grateful to be part of this work.

@ACCinTouch @JACCJournals

[Shikha Jha M.D.🫀 @Shikha_Cardio]

Instant ♥️ connections!! #FIT #ACC2026
@ACCinTouch @harsh_cardio @nair_ambica and Divya.

[Omar Al Ta'ani @OmarAlTaanii]

Very excited to share that I will be pursuing my GI fellowship at @WashUMedGastro!

Grateful every day for the incredible support from my family, friends, and mentors who made this possible.

Looking forward to the journey ahead! 🎉

@AHNIMres @TKapetanos

[Divya Patel @impateldivya]

@AHNIMres @SN_Ophthalmol @TKapetanos Thank you!

[Divya Patel @impateldivya]

Excited to share our cross-sectional study on the Prevalence & Characteristics of Charles Bonnet Syndrome (CBS) in Glaucoma Patients published in @SN_Ophthalmol

🧠 Key Findings:
• CBS prevalence: 11.5% in glaucoma patients
• Occurs even with relatively good visual acuity
• Often misdiagnosed as psychiatric illness
• Common hallucinations: simple visual phenomena (lines, flickers)
• Significant psychosocial impact & reduced quality of life

Our findings highlight the need for greater clinician awareness, early identification, and patient counseling to avoid misdiagnosis & improve outcomes.

🔗 Read here: https://t.co/Y5DITtH41z

@AHNIMres @TKapetanos

#SpringerNature #Ophthalmology #Glaucoma #CharlesBonnetSyndrome #EvidenceBasedMedicine

[Divya Patel @impateldivya]

@AHNIMres @AmJCardio @thakkar_samarth @nair_ambica @harsh_cardio @SachinGoelMD @SyedZaidMD @AlpeshShahMD @Joe_Aoun_ @HassaanBArshad1 @ShilpAroraMD @TKapetanos Thank you!

[Divya Patel @impateldivya]

Excited to share our retrospective cohort study in @AmJCardio on Adjunctive Thrombectomy during PCI in STEMI!

🧠 Key Findings:

• No increased risk of stroke at 30 days or 1 year.
• No difference in all-cause mortality.
• No difference in the utilization of MCS (IABP, Imeplla and ECMO) at 30 days.
• Higher 1-year HF readmissions with thrombectomy.

While routine use is not supported, findings endorse selective use based on thrombus burden, clinical context & procedural complexity.

📎https://t.co/5D2oYP6BbI

@thakkar_samarth Safi Khan @nair_ambica @harsh_cardio @ParthDesaiMD @SyedZaidMD @ShilpAroraMD @Joe_Aoun_ @SachinGoelMD @AlpeshShahMD Neil Kleiman

@AHNIMres

#Cardiology #Thrombectomy #PCI #EvidenceBasedMedicine